These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 2428231)

  • 1. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper.
    Koller A; Laughlin MH; Cenko E; de Wit C; Tóth K; Bugiardini R; Trifunovits D; Vavlukis M; Manfrini O; Lelbach A; Dornyei G; Padro T; Badimon L; Tousoulis D; Gielen S; Duncker DJ
    Cardiovasc Res; 2022 Jan; 118(2):357-371. PubMed ID: 34358290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic nitric oxide synthase inhibition on V'O
    Wojewoda M; Przyborowski K; Sitek B; Zakrzewska A; Mateuszuk L; Zoladz JA; Chlopicki S
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):235-244. PubMed ID: 27915453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice.
    Przyborowski K; Wojewoda M; Sitek B; Zakrzewska A; Kij A; Wandzel K; Zoladz JA; Chlopicki S
    PLoS One; 2015; 10(6):e0130908. PubMed ID: 26115505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations on the management of pulmonary hypertension in clinical practice.
    British Cardiac Society Guidelines and Medical Practice Committee, and approved by the British Thoracic Society and the British Society of Rheumatology
    Heart; 2001 Sep; 86 Suppl 1(Suppl 1):I1-13. PubMed ID: 11473937
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.
    Higenbottam TW; Butt AY; Dinh-Xaun AT; Takao M; Cremona G; Akamine S
    Heart; 1998 Feb; 79(2):175-9. PubMed ID: 9538312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beraprost sodium, a new prostaglandin I2 analog, on parameters of hemostasis, fibrinolysis, and myocardial ischemia in patients with exertional angina.
    Sakata K; Hoshino T; Yoshida H; Kaburagi T; Takada A
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):601-7. PubMed ID: 8547211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation.
    Schrör K; Thiemermann C; Ney P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):268-74. PubMed ID: 2848205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.
    Grant SM; Goa KL
    Drugs; 1992 Jun; 43(6):889-924. PubMed ID: 1379160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel fluoroprostacyclin analogs with modified cycloalkylenyl chains. Highly potent and orally active anti-anginal agents.
    Matsumura Y; Asai T; Shimada T; Nakayama T; Urushihara M; Morizawa Y; Yasuda A; Yamamoto T; Fujitani B; Hosoki K
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):353-5. PubMed ID: 7537179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PGI2 and its stable analog on platelet function in hyperlipoproteinemia.
    Maderna P; Tremoli E; Colli S; Paoletti R
    Pharmacol Res Commun; 1988 Sep; 20 Suppl 3():85-99. PubMed ID: 2465554
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of iloprost, a stable prostacyclin analog, on exercise capacity and platelet aggregation in stable angina pectoris.
    Bugiardini R; Galvani M; Ferrini D; Gridelli C; Mari L; Puddu P; Lenzi S
    Am J Cardiol; 1986 Sep; 58(6):453-9. PubMed ID: 2428231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris.
    Grauso F; Biagi G; Puddu P; Bugiardini R; Capelli M; Coccheri S
    Thromb Res; 1987 Oct; 48(2):131-43. PubMed ID: 2447664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST/HR slope during prostacyclin treatment: an improved method to identify patients with advanced coronary artery disease.
    Bugiardini R; Borghi A; Morgagni G; Pozzati A; Ottani F; Nicolini FA; Puddu P
    Eur Heart J; 1989 Nov; 10(11):991-7. PubMed ID: 2480239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise decreases the platelet sensitivity to prostacyclin in patients with angina pectoris.
    Kristensen SD; Schmidt EB; Andersen HR; Dyerberg J
    Prostaglandins Leukot Med; 1985 Oct; 20(1):45-54. PubMed ID: 3906669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study.
    Darius H; Hossmann V; Schrör K
    Klin Wochenschr; 1986 Jun; 64(12):545-51. PubMed ID: 2426514
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.